Annovis Bio, Inc.
Annovis Bio, Inc. (ANVS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
anvs · stock forecast · 8 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$30.00
Consensus
$25.67
+1334.1% upside
Low
$21.00
Median: $26 · Last Close: $1.79
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.71 | ↓ 4.40% |
1-day model range: $1.67–$1.75. Peak: $1.75 (-4.40%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ANVS · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-14 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-09-30 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-09-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-15 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-02-10 | D. Boral Capital | Downgrade ↓ | Buy→Hold |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | D. Boral Capital | Maintains | Buy→Buy |
| 2024-10-25 | Maxim Group | Upgrade ↑ | Hold→Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Annovis Bio, Inc. (ANVS) stock. Of the recent 30 rating actions, 1 were upgrades and 2 were downgrades. 8 analysts currently cover ANVS.
Analyst Recommendation Trends
ANVS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$11M
↓ 78.3% YoY
Revenue Next Year
$17M
↑ 52.5% YoY
EPS This Year
$-1.86
EPS Next Year
$-1.55
↓ 16.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ANVS EPS of $-1.86 for the current fiscal year, based on estimates from 1 analysts. The ANVS revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ANVS stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ANVS price target is $25.67 (+1334.1% upside), with an analyst consensus of Buy.
The ANVS short-term stock prediction for tomorrow is $1.71 (-4.40%). The ANVS stock prediction for 2030 projects a range of $1–$1.
Annovis Bio, Inc. trades on NYSE under the ticker ANVS. The ANVS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
ANVS forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month ANVS price target is $25.67, with a high forecast of $30.00 and a low of $21.00. The median price target is shown in the chart above when available. This implies +1334.1% potential upside from the current price of $1.79.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.